Literature DB >> 9189833

Perception of risk, choice of maternity site, and socio economic level of twin mothers.

E Papiernik1, J Tafforeau, A Richard, J C Pons, L G Keith.   

Abstract

The objective of this study was to determine if access to high level health facility (level 3 perinatal center) is related to socio-economic level of the mother and to her perception of risk for a twin birth. A retrospective questionnaire was administrated to the mothers of twins during the first post parum days in each of the 27 maternity sites within a defined geographical district near Paris (Hauts de Seine). The survey instrument was designed to precisely characterize the socioeconomic status of the parents, to measure the perceived risk for the twins expressed by the mother, to measure the relationship between the choice of a maternity site (level 1, 2 or 3) by socioeconomic level, and to measure the fetal and neonatal death rates by socioeconomic status. The opinion of mothers of twins about specific risk for her and for her children is very different by socioeconomic levels, as is the choice of level 3. This is discussed with the rates of fetal and neonatal death rates by socioeconomic level. In the absence of a policy of regionalization of perinatal care, the discriminant factor for access to high level care (level 3 maternity site) is the socioeconomic level.

Entities:  

Mesh:

Year:  1997        PMID: 9189833     DOI: 10.1515/jpme.1997.25.2.139

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  2 in total

1.  Severe maternal morbidity and its associated factors: A cross-sectional study in Morang district, Nepal.

Authors:  Sushma Rajbanshi; Mohd Noor Norhayati; Nik Hussain Nik Hazlina
Journal:  PLoS One       Date:  2021-12-31       Impact factor: 3.240

2.  Risk perceptions among high-risk pregnant women in Nepal: a qualitative study.

Authors:  Sushma Rajbanshi; Mohd Noor Norhayati; Nik Hussain Nik Hazlina
Journal:  BMC Pregnancy Childbirth       Date:  2021-08-04       Impact factor: 3.007

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.